Skip to main content

Table 1 Baseline demographic and clinical characteristics according to COPD diagnosis

From: Impact of chronic obstructive pulmonary disease on short-term outcome in patients with ST-elevation myocardial infarction during COVID-19 pandemic: insights from the international multicenter ISACS-STEMI registry

Variables

COPD (n = 810)

Non COPD (n = 14,876)

P-value

Age, years—median, IQR)

68 (61–76)

62 (54–71)

 < 0.001

Age > 75 year—n. (%)

229 (28.3)

2711 (18.2)

 < 0.001

Male gender—n. (%)

603 (74.4)

11,269 (75.8)

0.398

Diabetes mellitus—n (%)

235 (29.0)

3526 (23.7)

0.001

Hypertension—n (%)

545 (67.3)

8095 (54.4)

 < 0.001

Hypercholesterolemia—n (%)

412 (50.9)

5824 (39.2)

 < 0.001

Active smoker—n (%)

567 (70.0)

7963 (53.5)

 < 0.001

Family history of CAD—n (%)

150 (18.5)

3013 (20.3)

0.231

Previous STEMI—n (%)

127 (15.7)

1374 (9.2)

 < 0.001

Previous PCI—n (%)

160 (19.8)

1781 (12.0)

 < 0.001

Previous CABG—n (%)

20 (2.5)

242 (1.6)

0.068

Geographic area

  

 < 0.001

Europe n (%)

725 (89.5)

11,692 (78.6)

 

Latin-America—n (%)

61 (7.5)

1289 (8.7)

 

South East Asia—n (%)

21 (2.6)

1272 (8.6)

 

North Africa—n (%)

3 (0.4)

623 (4.2)

 

Referral to primary PCI hospital

  

0.388

Ambulance (from community)—n (%)

383 (47.5)

7136 (48.0)

 

HUB—n (%)

215 (26.5)

4175 (28.1)

 

Spoke—n (%)

210 (25.9)

3565 (24.0)

 

Time delays

   

Ischemia time, minutes—median (IQR)*

210 (129–370)

210 (121–379)

0.786

Total Ischemia time > 12 h—n (%)

89 (11.0)

1527 (10.3)

0.510

Door-to-balloon time, minutes—median (IQR)*

40 (26–60)

40 (25–70)

0.709

Door-to-balloon time > 30 min (%)—n (%)

506 (62.5)

9102 (61.2)

0.465

Clinical presentation

   

Anterior STEMI—n (%)

335 (41.4)

6940 (46.7)

0.003

Out-of-hospital cardiac arrest—n (%)

48 (5.9)

908 (6.1)

0.953

Cardiogenic shock—n (%)

83 (10.2)

1081 (7.3)

0.007

Rescue PCI for failed thrombolysis—n (%)

50 (6.2)

1049 (7.1)

0.340

  1. COPD  chronic obstructive pulmonary disease, CAD  coronary artery disease, STEMI  ST-segment elevation myocardial infarction, PCI  percutaneous coronary intervention, CABG 0 coronary artery bypass graft
  2. *Mann–Whitney test